When top hedge fund managers start humming the same tune, it’s like a chorus of songbirds signaling a potentially hidden melody worth listening to. In the latest 13F filings review carried out by Holdings Channel, the spotlight falls on Gilead Sciences Inc (Symbol: GILD), held dear by 10 of the 30 most recent filers – a figure that beckons a closer inspection.
However, before we dive deep, it’s prudent to remember that while 13F filings offer a peek into long positions, the clandestine art of short selling remains under wraps. Just like an iceberg, with only the visible tip on display, the full story lies concealed beneath the surface.
Peering into clusters of 13F filings can open windows into intriguing comparisons across different holding periods. Let’s now focus on the shift in GILD positions among this recent cohort of filers:
| Fund | New Position? | Change In Share Count | Change In Market Value($ in 1000’s) |
|---|---|---|---|
| Metis Global Partners LLC | Existing | +1,073 | –$211 |
| Aggregate Change: | –171,042 | –$41,463 | |
Among the highlighted funds, 3 increased their GILD positions, 5 decreased them, with 1 initiating a new position during this period. Scanning beyond this batch, the total GILD shares held by all funds in the 06/30/2024 period saw a 2.49% hike, amounting to 2,337,371 additional shares compared to the previous holdings.
Observing the historical context unveils intriguing narratives – akin to flipping through pages of old lore. The tale of hedge funds cradling GILD shares between 03/31/2024 and 06/30/2024 tells of a collective increase by 2,337,371 shares, a 2.49% surge from 93,776,056 to 96,113,427 shares. The stage is set, the act progresses.
We remain vigilant, a hawk eye on the horizon, sifting through the latest 13F filings churned out by hedge fund mavens. Unearthing compelling narratives brewing within the cumulative data across fund clusters from one filing period to the next. Despite the long-only constraints, these aggregated insights harbor intriguing stock prospects deserving further exploration – much like the enigma of Gilead Sciences Inc (Symbol: GILD).
